| Exploring therapeutic viability of a non-dopaminergic target for Parkinson’s disease |
| English |
| Ashrafi, Amer [] |
| Buttini, Manuel [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >] |
| Garcia, Pierre [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >] |
| del Sol Mesa, Antonio [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >] |
| Glaab, Enrico [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >] |
| 2016 |
| Movement Disorders |
| John Wiley & Sons |
| 31 |
| 2 |
| S630 |
| Yes (verified by ORBilu) |
| International |
| 0885-3185 |
| 1531-8257 |
| Hoboken |
| NY |
| 20th International Congress of Parkinson's Disease and Movement Disorders |
| 23-06-2016 |
| [en] Parkinson's disease ; RGS4 ; drug target |
| Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group) |
| Fonds National de la Recherche - FnR |
| FNR5782168 > Enrico Glaab > ExPDIENT > Exploring Parkinson’s Disease Inhibitor Efficacy on a Non-dopaminergic Target > 01/12/2013 > 31/05/2016 > 2013 |
| Researchers ; Professionals ; Students |
| http://hdl.handle.net/10993/39823 |
| FnR ; FNR5782168 > Enrico Glaab > ExPDIENT > Exploring Parkinson’s Disease Inhibitor Efficacy on a Non-dopaminergic Target > 01/12/2013 > 31/05/2016 > 2013 |